(NASDAQ: MDWD) Mediwound's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.14%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.23%.
Mediwound's earnings in 2025 is -$28,234,000.On average, 4 Wall Street analysts forecast MDWD's earnings for 2025 to be -$29,255,447, with the lowest MDWD earnings forecast at -$31,539,330, and the highest MDWD earnings forecast at -$27,080,321. On average, 6 Wall Street analysts forecast MDWD's earnings for 2026 to be -$27,153,188, with the lowest MDWD earnings forecast at -$35,345,801, and the highest MDWD earnings forecast at -$19,793,648.
In 2027, MDWD is forecast to generate -$23,404,358 in earnings, with the lowest earnings forecast at -$31,430,574 and the highest earnings forecast at -$18,923,598.